Project Grant HT94252410776
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$675K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98108, USA
Similar Awards
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,047,751 Project Grant to the Portland VA Research Foundation, Inc. to conduct the "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE" research project. This 4-year award, beginning on Sep 1, 2024 and ending on Aug 31, 2028, will enable the Portland VA Research Foundation to carry out scientific research aimed at improving health outcomes for...
The U.S. Department of the Army Medical Command awarded a $1,277,097 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE," aims to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The project will run from Sep...
The University of Sydney has been awarded a $384,996.51 project grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Sleep-Wake Disturbances as a Target for Novel Biomarkers and Therapies for Patients with Parkinson's Disease". The two-year project aims to investigate sleep-wake disruptions as potential biomarkers and develop new therapeutic approaches for managing Parkinson's disease. The research will be...
This $7.72 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The Seattle Institute for Biomedical and Clinical Research will define the role of post-traumatic brain injury sleep disruption and glymphatic dysfunction in the development of Alzheimer's disease and chronic traumatic encephalopathy neuropathology. Over three years, the grantee and three sub-awardees will...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
The Department of the Army Medical Command awarded a $751,936 Project Grant to the J. David Gladstone Institutes located in San Francisco, California. The grant period runs from September 26, 2022 through September 25, 2025. The grant supports research into the "Impact of Energy Failure on Alpha-Synuclein Spread and Neurodegeneration" under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through innovative...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The Defense Health Agency awarded a $365,623 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Fundacio De Recerca Clinic Barcelona-Institut D'investigacions Biomediques August Pi I Sunyer, a non-profit biomedical research organization in Barcelona, Spain. The grant, awarded on September 1, 2024, will support the development of a novel blood-based diagnostic test to detect alpha-synuclein aggregation as an indicator of Parkinson's disease. The...
This federal Project Grant award in the amount of $811,942 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the J. David Gladstone Institutes, a non-profit biomedical research organization, to investigate genetic factors conferring susceptibility to toxicant-induced Parkinson's disease. The research involves a sub-award to the Northern California Institute For Research And...
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...